Parkinson’s disease: What does the research say?

What is Parkinson’s disease?

Parkinson’s disease is a progressive neurological disorder marked by the degeneration of dopamine-producing neurons in a region of the brain called the substantia nigra. Dopamine is essential for coordinating movement, and its loss leads to characteristic motor symptoms such as resting tremors, muscle rigidity, slowness of movement (bradykinesia), and balance problems.

In addition to these motor symptoms, many people also experience non-motor symptoms, including fatigue, sleep disturbances, anxiety, depression and digestive issues such as constipation.

What are the known and suspected causes of Parkinson’s disease?

A complex and multifactorial origin

Most experts agree that Parkinson’s does not have a single cause. Instead, it likely results from a complex interaction of genetic, environmental, and biological factors. While rare hereditary forms exist, the majority of cases appear to be sporadic, meaning their origin is unclear.

Genetic factors

Several gene mutations have been associated with Parkinson’s. The LRRK2 gene is linked to some late-onset inherited forms. The PARKIN, PINK1, and DJ-1 genes are more commonly linked with early-onset Parkinson’s. These mutations can interfere with essential cellular processes such as mitochondrial function and protein recycling. However, they remain rare in the general population and do not explain most cases.

Pesticides and environmental toxins

Exposure to pesticides and other environmental toxins is one of the strongest risk factors studied. Prolonged contact with chemicals such as paraquat, rotenone, certain solvents, and heavy metals has been linked to a higher risk of Parkinson’s. These substances may contribute to oxidative stress and mitochondrial dysfunction, which gradually damage dopamine-producing neurons.

The gut microbiome and the gut-brain axis

In recent years, the role of the gut microbiome has gained increasing attention. Gastrointestinal symptoms like constipation often appear years before motor symptoms, suggesting that Parkinson’s might begin in the gut. Changes in the microbiome could trigger chronic inflammation, alter immune responses, and even promote the spread of abnormal proteins like alpha-synuclein, which accumulates in the brains of people with Parkinson’s.

Pollution, oxidative stress, and other environmental factors

Beyond pesticides, researchers are studying the impact of air pollution, industrial solvents, and oxidative stress. Oxidative stress occurs when harmful free radicals overwhelm the body’s natural defences, leading to accelerated cell ageing and neuronal death. This process is thought to contribute to Parkinson’s and other neurodegenerative diseases.

Diet, lifestyle, and overall health

Lifestyle may also play a role in Parkinson’s risk. Research suggests that a diet rich in antioxidants, fibre, and omega-3 fatty acids may help protect against neurodegeneration. By contrast, diets high in ultra-processed foods and low in nutrients may encourage inflammation and oxidative stress. Regular physical activity and effective stress management are also under investigation as protective factors.

What are researchers focusing on today?

Advances in genetics and epigenetics

Scientists continue to identify genes linked to Parkinson’s, but there is also growing interest in epigenetics, the way environmental exposures can influence how genes are expressed. This may explain why some people with genetic risks never develop Parkinson’s, while others do.

Studies on the gut microbiome and neuroinflammation

Many research teams are exploring how specific bacterial changes in the gut may drive inflammation in the brain. This area of study could open the door to new therapeutic approaches such as probiotics, prebiotics, or even faecal microbiota transplantation as a way to slow or prevent Parkinson’s progression.

Identifying biomarkers for earlier diagnosis

A major goal of current research is to discover reliable biomarkers that would allow Parkinson’s to be diagnosed before motor symptoms appear. Potential biomarkers include abnormal proteins in blood or cerebrospinal fluid, genetic signatures, or distinctive microbiome profiles. Earlier detection could enable earlier intervention and improved outcomes.

Toward personalized prevention

In the future, combining genetic information, environmental exposure histories, and biological data may make it possible to predict an individual’s risk of Parkinson’s and tailor prevention strategies to their unique profile. This personalized or predictive medicine is one of the most promising areas of research for neurodegenerative diseases.

In summary

Parkinson’s disease remains a complex condition shaped by the interaction of genetic, environmental, and biological factors. Although no single cause has been identified, advances in research are shedding light on the mechanisms involved. From genetic studies to microbiome research, scientists are making progress toward earlier detection and more targeted prevention.

The future lies in better understanding these risk factors, improving diagnostic tools, and developing personalized approaches that could change the course of Parkinson’s disease. While there is still no definitive prevention strategy, science is steadily moving us closer to a world where Parkinson’s is more manageable, or even preventable.

If you found this article helpful, feel free to give it a “Like” and share your thoughts and questions with the community in the comments below!

Take care!